Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Recent scientific studies have shown promising advancements in medical treatments. A personalized vaccine significantly ...

People are also enquiring whether cancer will be a disease of the past like polio or measles after the vaccine is available ...

A survey of the nation's oncologists showed that professional burnout has reached a new high (59% vs 45% in 2013), and fewer ...

Pharmaceutical giant GSK and the University of Oxford are collaborating on developing a cancer vaccine that aims to detect pre-cancer cells up to 20 years before they become malignant. This innovative ...

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

A potential new cancer vaccine could be on the horizon as a study has yielded “exciting” results. Scientists have revealed that a new jab could successfully eliminate a type of kidney cancer.

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

A new personalized immunotherapy treatment called a cancer vaccine has shown promising results in a phase I trial in people with kidney cancer. The results from nine patients treated at Dana ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults.

Personalized cancer vaccines showed significant immune responses in stage III/IV renal cell carcinoma patients, with T-cells increasing 166-fold and persisting for up to three years. The vaccine ...